Ignite Creation Date:
2024-05-05 @ 11:54 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00179738
Status:
TERMINATED
Last Update Posted:
2005-11-23
First Post:
2005-09-10
Brief Title:
A Multicenter Single-Arm Open-Label Study to Evaluate the Safety and Efficacy of Single-Agent Lenalidomide Revlimid CC-5013 in Subjects With Androgen Independent Prostate Cancer
Sponsor:
Organization:
Celgene